An updated patent review of GLP-1 receptor agonists (2020-present)
{{output}}
Introduction: Type 2 diabetes (T2DM) and obesity present significant global health issues, requiring the development of long-lasting and highly effective pharmacotherapies. Although glucagon-like peptide-1 receptor agonists (GLP-... ...
